U.S., Sept. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07173660) titled 'Consensus Statements on Deep Brain Stimulation in Patients With Parkinson's Disease' on Sept. 07.
Brief Summary: Deep brain stimulation (DBS) has become a cornerstone therapy for advanced Parkinson's disease (PD), demonstrating superior outcomes compared with best medical treatment in randomized clinical trials. By delivering adjustable electrical stimulation to key basal ganglia targets, DBS effectively improves tremor, rigidity, bradykinesia, and motor fluctuations, while also reducing dopaminergic medication requirements. The success of DBS, however, depends not only on precise surgical targeting but also on careful patient sele...